95PPredicting toxicity and response to pembrolizumab (P) through germline genomic HLA class I analysis. (23rd October 2018) - Iafolla, M; Yang, C; Chandran, V; Pintilie, M; Hansen, A; Bedard, P; Lheureux, S; Spreafico, A; Razak, A; Ohashi, P; Hakgor, S; Giesler, A; et al.